ArticleClinical drug investigation2012

Three-year experience with risedronate therapy for patients with an increased fracture risk: assessment of proximal femoral bone density and geometry by DXA.

Masayuki Takakuwa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.